Treatment of Larynx Cancer - Is There No Financial Anything New? Disclosures Eric Wirtz, MD February 15, 2020
VA Larynx Trial • 39% of patients in chemotherapy group survived with functioning larynx • Salvage laryngectomy • 41% of patients with fixed vocal cords • 44% of stage IV patients • 56% of patients with T4 cancers
NCCN Guidelines Summary • T4 disease - Surgery + adjuvant therapy • T3 disease - ? Bioselection • T2/T1 disease - uni-modality treatment
Recommend
More recommend